According to GuruFocus Insider Data, these are the largest CFO buys during the past week. The overall trend of CFOs is illustrated in the chart below:
Cytrx Corp (NASDAQ:CYTR): CFO John Y Caloz Bought 31,792 Shares
CFO of Cytrx Corp (NASDAQ:CYTR) John Y Caloz bought 31,792 shares on 02/23/2012 at an average price of $0.32. CYTRX CORP. is engaged in the development and commercialization of pharmaceutical related products and services including human therapeutics focused on high-value critical- care therapies. Cytrx Corp has a market cap of $50.66 million; its shares were traded at around $0.3413 with and P/S ratio of 506.58.
CytRx Corporation reported financial results for the three months and nine months ended September 30, 2011. CytRx reported a net loss of $0.6 million, or $0 per share, and comprehensive loss of $0.8 million, for the third quarter of 2011.
CEO Steven A Kriegsman, CFO John Y Caloz, and Director Richard L. Wennekamp bought shares of CYTR stock.
Adv Photonix -A (API): CFO Jeffrey J Anderson Bought 20,224 Shares
CFO of Adv Photonix -A (API) Jeffrey J Anderson bought 20,224 shares on 02/28/2012 at an average price of $0.75. Advanced Photonix, Inc. is engaged in the development and manufacture of optoelectronic semiconductor based components, hybrid assemblies and other proprietary solid state light and radiation detection devices, including proprietary advanced solid state silicon photodetection devices which utilize Avalanche Photodiode technology. Adv Photonix -a has a market cap of $25.39 million; its shares were traded at around $0.82 with a P/E ratio of 82 and P/S ratio of 0.88.
Advanced Photonix, Inc. issued a press release announcing its results for the third quarter ending December 30, 2011. The Company's revenues for the quarter ended December 30, 2011 were $6.5 million, a decrease of 16% (or $1.2 million) over revenues of $7.7 million for the quarter ended December 31, 2010. Quarterly net loss was $812,000 or $0.03 per diluted share, as compared to a net loss of $649,000, or $0.03 per diluted share, for the quarter ended December 31, 2010.
CFO Jeffrey J Anderson, Director Lance Brewer, and Director Donald Pastor shares of API stock on 11/30/2011 at the average price of 0.55. Donald Pastor owns at least 147,783 shares after this.
Corelogic Inc (NYSE:CLGX): CFO Frank Martell Bought 15,000 Shares
CFO of Corelogic Inc (NYSE:CLGX) Frank Martell bought 15,000 shares on 03/01/2012 at an average price of $15.4. CoreLogic, Inc., formerly known as First American Corp. Corelogic Inc has a market cap of $1.65 billion; its shares were traded at around $15.5 with a P/E ratio of 18.67 and P/S ratio of 1.23.
CoreLogic reported financial results for the fourth quarter and full-year ended December 31, 2011. Fourth quarter revenues were up 9.5% from the previous year. Full year 2011 revenues were up 4.6% from the previous year.
CFO Frank Martell bought shares of CLGX stock.
Plumas Bancorp (NASDAQ:PLBC): SVP, CFO Richard L Belstock Bought 6,569 Shares
SVP, CFO of Plumas Bancorp (NASDAQ:PLBC) Richard L Belstock bought 6,569 shares on 02/22/2012 at an average price of $2.49. PLUMAS BANCORP is a bank holding company of Plumas Bank. Plumas Bancorp has a market cap of $20.06 million; its shares were traded at around $4.2 with a P/E ratio of 70 and P/S ratio of 0.78.
Plumas Bancorp announced fourth quarter net income of $245 thousand compared to net income of $65 thousand for the fourth quarter of 2010, an improvement of $180 thousand. For the year ended December 31, 2011, Plumas Bancorp reported net income of $941 thousand as compared to net income of $971 thousand for the year ended December 31, 2010.
SVP, CFO Richard L Belstock, Director Daniel E West, and Director John Flournoy bought shares of PLBC stock.
Arthrocare Corp (NASDAQ:ARTC): SVP, CFO & COO Todd Newton Bought 4,000 Shares
SVP, CFO & COO of Arthrocare Corp (NASDAQ:ARTC) Todd Newton bought 4,000 shares on 02/29/2012 at an average price of $26.2. ArthroCare Corp. is a medical device company that develops, manufactures and markets products based on its patented Coblation technology. Arthrocare Corp has a market cap of $715.68 million; its shares were traded at around $25.94 with a P/E ratio of 11.58 and P/S ratio of 2.02.
ArthroCare Corp. announced its financial results for the fourth quarter and year ended December 31, 2011 Total revenue for the fourth quarter of 2011 was $92.4 million, compared to $92.6 million for the fourth quarter of 2010. Net loss attributable to common stockholders was $29.3 million or $1.06 per share in the fourth quarter of 2011, compared to net income of $10.1 million, or $0.30 per diluted share, in the fourth quarter of 2010.
SVP, CFO & COO Todd Newton and Board of Directors David Fitzgerald bought shares of ARTC stock.
CTO and SVP Jean Woloszko and Chief Regulatory Officer & SVP Bruce Prothro sold shares of ARTC stock.
For the complete list of stocks that bought by their CFOs, go to: Insider Buys.
- CEO Buys, CFO Buys: Stocks that are bought by their CEO/CFOs.
- Insider Cluster Buys: Stocks that multiple company officers and directors have bought.
- Double Buys:: Companies that both Gurus and Insiders are buying
- Triple Buys: Companies that both Gurus and Insiders are buying, and Company is buying back.